Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar · Clinical Investigation · 2011
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Clinical Investigation · OMICS Publishing Group · article · 2011
Abstract
Sumathi Nambiar is deputy director for safety in the division of anti-infective products at the US FDA. She has participated in discussions between industry, academia and regulatory bodies in workshops designed to address the current concerns regarding non-inferiority design in antibacterial trials, and has also contributed towards the follow-up guidance released by the FDA. Sumathi Nambiar spoke with Laura Harvey at Clinical Investigation on some of the key issues facing clinical trials in this arena.
Open the resolved locator · 10.4155/cli.11.78
Metadata licence: OpenAlex metadata (CC0)